1. Home/
  2. Compounds/
  3. SNX-2112:bortezomib (250:1 mol/mol)

SNX-2112:bortezomib (250:1 mol/mol)

Synonyms

SourcesNames Used
CTRPv2SNX-2112:bortezomib (250:1 mol/mol)
PharmacoGx SNX-2112:bortezomib (250:1 mol/mol)

FDA Approval Status

Not Approved
Dataset Select
Download Data as CSV

Top molecular features associated with response to SNX-2112:bortezomib (250:1 mol/mol)


Feature TypeStandardized
Nominal ANOVA
mRNA SLIT3 CTRPv2 pan-cancer AAC -0.24 9e-10
mRNA CEP295NL CTRPv2 pan-cancer AAC -0.22 4e-08
mRNA TIMP2 CTRPv2 pan-cancer AAC -0.2 3e-07
mRNA AGRN CTRPv2 pan-cancer AAC -0.18 3e-06
mRNA ZBTB4 CTRPv2 pan-cancer AAC -0.18 5e-07
mRNA CTSA CTRPv2 pan-cancer AAC -0.18 6e-07
mRNA LAMA5 CTRPv2 pan-cancer AAC -0.18 2e-06
mRNA CD151 CTRPv2 pan-cancer AAC -0.18 7e-06
mRNA FAM114A1 CTRPv2 pan-cancer AAC -0.18 8e-06
mRNA GRAMD3 CTRPv2 pan-cancer AAC -0.17 7e-07
Download CSV